#SingleCell #RNASeq Reveals Dynamic, Random Monoallelic Gene Expression, occurring in ~20% of genes in mice cells
http://science.sciencemag.org/content/343/6167/193.abstract
Talk About the #Weather, has evolved from mystic reflections to scientific forecasts, in pop culture & literature
http://www.newyorker.com/magazine/2015/11/23/writers-in-the-storm
Glycan Notation Standardized http://cen.acs.org/articles/94/i1/Glycan-Notation-Standardized-Last.html Merging 2 systems: essentials (sugars) & Oxford (bonds/angles). A prereq. for glycomics
QT:{{"Carbohydrate chemists and glycobiologists have now agreed on an expanded and standardized symbol nomenclature based primarily on the Essentials notation (Glycobiology 2015, DOI:10.1093/glycob/cwv091). The agreement “is a major step, as without a common vocabulary and language the glycosciences cannot advance as genomics and proteomics have,” says carbohydrate chemist Peter H. Seeberger of the Max Planck Institute of Colloids & Interfaces. For nonglycan experts, here we explain the two notation systems. ▪
…
The newly standardized Essentials system permits an optional mixed form of notation in which the Oxford system’s angles and dashed and solid bonds are used but its sugar symbols are not.
"}}
It’s Time to End the War on #Salt
http://www.scientificamerican.com/article/its-time-to-end-the-war-on-salt/ Meta analyses of previous studies fail to show link to blood pressure or mortality
IBM attrium + nearby starbucks
http://obica.com/portal/US/en/dove-siamo/restaurant-new-york/ny-madison/ M-F 7a-6p, Sa 9a-, Su 10a-
Health ROI as a measure of misalignment of…needs & resources by @arzhetsky http://www.nature.com/nbt/journal/v33/n8/full/nbt.3276.html See funding decisions like stock trades
QT:{{"In a recently published letter to Nature Biotechnology, Lixia Yao,
IGSB core faculty Andrey Rzhetsky and colleagues dissect the decisions
made in funding choices. His team compares these choices by funding
agencies to trades in a financial market. In this communication, they
expand on the idea that there exists an imbalance between health needs
and biomedical research investment.
In order to fairly examine the relationship between biomedical need
and biomedical research, they validated a new, insurance based measure
of health burden that enables automatic evaluation of burden and
research investment for many more diseases than have been previously
assessed. "
"}}